| Presentation | Webcast |
November 17, 2023Presentation - Vivesto - Paccal Vet redo för nästa steg | | |
October 26, 2023Interview Erik Penser Bank | | |
August 24, 2023Presentation - EPB Bolagsdag | | |
May 25, 2023Presentation Erik Penser Bank | | |
May 5, 2022Anglonordic Life Science Conference | | |
March 14, 2022Oasmia Pharmaceutical – Aktiedagen Stockholm | | |
January 19, 2022Rights Issue Presentation at Erik Penser Bank | | |
December 2, 2021Presentation at Stora Aktiedagen Stockholm | | |
December 2, 2021Oasmia - Presentation Erik Penser Bank | | |
October 21, 2021Interview Erik Penser Bank | | |
September 29, 2021Naventus LifeScience Summit | | |
September 7, 2021Presentation at Aktiedagen Stockholm | | |
June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical | | |
April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting | | |
March 21, 2021BioEurope Spring, Virtual | | |
March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual | | |
March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil | | |
January 19, 2021SEB Digital Healthcare Seminar Presentation | | |
December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer | | |
November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference | | |
October 29, 2020BIO-Europe®, Virtual Conference | | |
October 7, 2020Oasmia Erik Penser Cancer Day Presentation | | |
September 24, 2020Oasmia Erik Penser Investor Event Presentation | | |
September 21, 2020Presentation at Sachs Biotech in Europe Forum | | |
September 15, 2020Aktiedagen Digitalt | | |
July 30, 2020Analysguiden: Interview with Oasmia | | |
June 10, 2020Company Presentation Aktiespararna | | |
June 3, 2020Avanza Börsdag | | |
May 13, 2020Strategic Review Presentation | | |
March 25, 2020Elevar deal | | |
February 14, 2020Oasmia appoints new CEO | | |
December 1, 2023Swiss Nordic Bio | | |